- Home
- BHAT vs PHGE Comparison
BHAT vs PHGE Comparison
Compare BHAT & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- PHGE
- Stock Information
- Founded
- BHAT 2010
- PHGE 2015
- Country
- BHAT China
- PHGE Israel
- Employees
- BHAT N/A
- PHGE N/A
- Industry
- BHAT Recreational Games/Products/Toys
- PHGE Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- PHGE Health Care
- Exchange
- BHAT Nasdaq
- PHGE Nasdaq
- Market Cap
- BHAT 10.3M
- PHGE 11.0M
- IPO Year
- BHAT 2019
- PHGE N/A
- Fundamental
- Price
- BHAT $1.84
- PHGE $0.39
- Analyst Decision
- BHAT
- PHGE Strong Buy
- Analyst Count
- BHAT 0
- PHGE 1
- Target Price
- BHAT N/A
- PHGE $15.00
- AVG Volume (30 Days)
- BHAT 158.9K
- PHGE 3.0M
- Earning Date
- BHAT 04-30-2025
- PHGE 08-13-2025
- Dividend Yield
- BHAT N/A
- PHGE N/A
- EPS Growth
- BHAT N/A
- PHGE N/A
- EPS
- BHAT N/A
- PHGE N/A
- Revenue
- BHAT $18,724,190.00
- PHGE N/A
- Revenue This Year
- BHAT N/A
- PHGE N/A
- Revenue Next Year
- BHAT N/A
- PHGE N/A
- P/E Ratio
- BHAT N/A
- PHGE N/A
- Revenue Growth
- BHAT N/A
- PHGE N/A
- 52 Week Low
- BHAT $1.61
- PHGE $0.34
- 52 Week High
- BHAT $106.00
- PHGE $3.48
- Technical
- Relative Strength Index (RSI)
- BHAT 50.96
- PHGE 37.11
- Support Level
- BHAT $1.68
- PHGE $0.38
- Resistance Level
- BHAT $1.85
- PHGE $0.77
- Average True Range (ATR)
- BHAT 0.10
- PHGE 0.06
- MACD
- BHAT 0.01
- PHGE -0.00
- Stochastic Oscillator
- BHAT 65.71
- PHGE 6.52
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).